About Eskag Pharma Pvt Ltd
Data last updated: 02 June 2026
Eskag Pharma Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 February 1977, the company has been in operation for over 49 years.
Registered with ROC Kolkata under CIN U24234WB1977PTC030897.
Capital: an authorised share capital of ₹1.8 Cr and a paid-up capital of ₹1.68 Cr. It is led by directors Anil Kumar Agarwal and Sunil Kumar Agarwal.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ag – 112 Unit No – 4 8Th Flooor Baisakhi Sector – Ii Saltlake, Kolkata, West Bengal, India – 700091.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.92 Cr, a growth of 8.07% compared to the previous year.
The company has a workforce of approximately 594 employees as per the latest available data.
The company is associated with 2 brands - Eskag Sanjeevani, Eskag Pharma. As per MCA filings, the company has open charges of ₹126.84 Cr and satisfied charges of ₹35.15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eskag.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressAg – 112 Unit No – 4 8Th Flooor Baisakhi Sector – Ii Saltlake, Kolkata, West Bengal, India – 700091
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd operates two associated brands: Eskag Sanjeevani and Eskag Pharma. These brands represent Eskag Pharma Pvt Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Operates as a standalone multi-speciality hospital offering comprehensive medical care. | eskagsanjeevani.com | |
| Manufactures and supplies pharmaceutical products for therapeutic areas like dermatology and gastroenterology. | eskag.in |
Competitors & Alternatives of Eskag Pharma Pvt Ltd
Brands and companies operating in the same space as Eskag Pharma Pvt Ltd include KIMS Hospitals, Fortis Healthcare, Ujala Cygnus and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Multispeciality secondary and tertiary care is provided by hospital chains. | Secunderabad, India, India | 1999 |
|
|
Multi-specialty hospital services are provided across India by Fortis Healthcare. | Gurugram, India, India | 1996 |
|
|
A chain of multi-specialty hospitals is operated in India. | Delhi, India, India | 2011 |
|
|
Chain of multi-speciality hospitals | Chennai, India, India | 1999 |
|
|
Chain of multispecialty hospitals | Chennai, India, India | 1983 |
|
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
|
|
Multi-speciality hospitals are operated with diverse medical services in India. | Pune, India, India | 1994 |
|
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
|
|
A chain of multi-specialty hospitals is operated in India. | Bengaluru, India, India | 2000 |
|
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Business Activity of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | and botanical products Manufacture of pharmaceuticals, medicinal chemical | Locked |
Detailed business activity records for Eskag Pharma Pvt Ltd
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd is audited by MAHENDRA SUBHAS & CO for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAHENDRA SUBHAS & CO | Locked | Locked | Locked |
Complete auditor history for Eskag Pharma Pvt Ltd
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Anil Kumar Agarwal
Also directs:
Upashaya Healthcare Llp, Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd. and 5 more
|
Director | 11 May 2005 | 21 Years 3 Months | Current |
|
Sunil Kumar Agarwal
Also directs:
Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd., Bhagirathi Commodities Private Limited and 5 more
|
Director | 13 Jun 1984 | 42 Years 2 Months | Current |
Financials of Eskag Pharma Pvt Ltd FY 2025 filings available
Eskag Pharma Pvt Ltd reported revenue of ₹82.92 Cr (up 8.07% YoY) for FY 2025.
Ten-year financial statements for Eskag Pharma Pvt Ltd
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Eskag Pharma Pvt Ltd
Shareholding and ownership data for Eskag Pharma Pvt Ltd
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eskag Pharma Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2023 | Standard Chartered Bank | ₹15 Cr | Open |
| 28 Jun 2021 | Standard Chartered Bank | ₹17.57 Cr | Open |
| 21 Jan 2020 | Hdfc Bank Limited | ₹77.58 Cr | Open |
| 29 Dec 2018 | Others | ₹44.5 Lakh | Open |
| 02 Feb 2018 | Hdfc Bank Limited | ₹13.4 Cr | Open |
Total charge records: 12 View all charges
Employees and EPFO Compliance at Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd has a workforce of 594 employees as of Oct 09, 2025.
Employee and EPFO history for Eskag Pharma Pvt Ltd
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Eskag Pharma Pvt Ltd
GST registrations and filing compliance for Eskag Pharma Pvt Ltd
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Eskag Pharma Pvt Ltd
Credit ratings, litigation, and regulatory alerts for Eskag Pharma Pvt Ltd
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eskag Pharma Pvt Ltd
MSME payment history for Eskag Pharma Pvt Ltd
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eskag Pharma Pvt Ltd
Corporate group structure for Eskag Pharma Pvt Ltd
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eskag Pharma Pvt Ltd
MCA filings and documents for Eskag Pharma Pvt Ltd
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Eskag Pharma Pvt Ltd
Frequently Asked Questions about Eskag Pharma Pvt Ltd
Eskag Pharma Pvt Ltd is an active private limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 24 February 1977 (49+ years old) and is registered under CIN U24234WB1977PTC030897. The company has 594 employees.
Eskag Pharma Pvt Ltd reported revenue of ₹82.92 Cr for FY 2025 (up 8.07% YoY).
The current directors of Eskag Pharma Pvt Ltd are:
- Anil Kumar Agarwal - Director
- Sunil Kumar Agarwal - Director
The primary industry of Eskag Pharma Pvt Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Eskag Pharma Pvt Ltd can be reached at the registered office: Ag – 112 Unit No – 4 8Th Flooor Baisakhi Sector – Ii Saltlake, Kolkata, West Bengal, India – 700091, or through the website eskag.in.
The authorised capital is ₹1.8 Cr, and the paid-up capital is ₹1.68 Cr.